Meanwhile, the banned treatments ...
“HCQ, alone or in any association, was associated with significant protection from death among outpatients (0.41, 0.21-0.79) and inpatients (0.59, 0.47-0.73).HCQ prescribed early or late protects in part from COVID-19-related death.”
https://www.medrxiv.org/content/10.1101 ... 23287649v1
TGA Australia has announced today (3 May 2023), that from 1 June 2023, prescribing of oral Ivermectin for ‘off-label’ uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious diseases specialists.
